LABCORP HOLDINGS INC. Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net
LABCORP HOLDINGS INC. (LH) had Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net of $63.50 million as of 2025-06-30, per its 10-Q filed 2025-08-01.
Financial Statements › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less), and Goodwill › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less)
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet · last filed 2025-08-01
- 2025-06-30: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net $63.50M.
- 2025-03-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net $53.50M.
- 2024-12-31: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net $869.00M.
- 2024-09-30: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net $781.20M.
| Period end | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net |
|---|---|
| 2025-06-30 | $63.50M 10-Q · filed 2025-08-01 |
| 2025-03-31 | $53.50M 10-Q · filed 2025-04-29 |
| 2024-12-31 | $869.00M 10-K · filed 2025-02-25 |
| 2024-09-30 | $781.20M 10-Q · filed 2024-10-29 |
| 2024-06-30 | $323.10M 10-Q · filed 2024-08-02 |
| 2024-03-31 | $289.20M 10-Q · filed 2024-04-30 |
| 2023-09-30 | $516.70M 10-Q · filed 2024-10-29 |
| 2023-03-31 | $0.00 10-Q · filed 2024-04-30 |
| 2020-06-30 | $0.00 10-Q · filed 2020-07-31 |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-08 |
| 2019-12-31 | $0.00 10-K · filed 2020-02-28 |
| 2019-09-30 | $0.00 10-Q · filed 2019-10-31 |
| 2017-07-31 | $1.22B 10-K · filed 2019-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |